This federal contract award is for the delivery of IMOVAX Rabies vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,339.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 10, 2024. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/16/25, 12:43 AM